Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
Abstract MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competen...
Guardado en:
Autores principales: | Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, Zahra Gharailoo, Gheyath Nasrallah, Said Dermime, Kaspars Tars, Monique Vogel, Andris Zeltins, Martin F. Bachmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75e90d2e660e4495962a2ced6e6426ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
por: Xinyue Chang, et al.
Publicado: (2021) -
Editorial: Unconventional Animal Models in Infectious Disease Research – Part I
por: Nadin Younes, et al.
Publicado: (2021) -
Asymmetric cryo-EM reconstruction of phage MS2 reveals genome structure in situ
por: Roman I Koning, et al.
Publicado: (2016) -
Encapsulation mechanisms and structural studies of GRM2 bacterial microcompartment particles
por: Gints Kalnins, et al.
Publicado: (2020) -
Tissue Distribution of the MERS-Coronavirus Receptor in Bats
por: W. Widagdo, et al.
Publicado: (2017)